BioGenerator

Funding rounds backed by BioGenerator.

Export CSV
Funding disclosed in full
$35M
Median round
$35M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Allotera Therapeutics

Develops allogeneic, off-the-shelf CAR-T cell therapies for hematological malignancies

$35MSeries CBiotechUnited States
5 participantsBanc of CaliforniaBioGeneratorBlood Cancer United's Therapy Acceleration ProgramFidelity Management & Research CompanyLightchain Capital